FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
11/02/2024
Back to search
Official data from USPTO
QUVIVIQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
11/02/2024
Trademark type
Word
Nice classes
5
Filing date
07/06/2022
Registration date
04/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
04/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
FERRELL, KATHERINE
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "QUVIVIQ" with five circles formingan arch over the "VIV" letters in the mark.
Holders and representatives
Holders
Idorsia Pharmaceuticals Ltd
Representatives
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations intended for the prevention or treatment of cardiovascular diseaseshypertensioncerebral haemorrhages and sequela thereofkidney diseasespulmonary diseasesfibrotic diseasescystic fibrosisinflammatory diseasesallergy diseasesautoimmune diseases and disordersneurodegenerative diseases and disordersneurological diseases and disorderscentral nervous system diseases and disordersdementiainsomniaanxiety disordersaddictionseating disordersepilepsymetabolic disordersdiabetesglycolipid storage diseasesFabry disease and Fabry disease symptoms and sequelainfectious diseases and cancer
Publications
History of USPTO decisions and trademark events.
33 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/17/2024
FIMP
FINAL DISPOSITION PROCESSED
10/17/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/03/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2024
PUBO
PUBLISHED FOR OPPOSITION
01/16/2024
GPNX
NOTIFICATION PROCESSED BY IB
01/13/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/27/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/07/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/07/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/07/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/07/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/07/2023
RFNT
REFUSAL PROCESSED BY IB
07/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/10/2023
RFRR
REFUSAL PROCESSED BY MPU
06/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/27/2023
CNRT
NON-FINAL ACTION WRITTEN
04/26/2023
DOCK
ASSIGNED TO EXAMINER
04/20/2023
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
03/02/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
02/13/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/27/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/23/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/22/2022
Continuous trademark protection
Get notified about every new filing that threatens QUVIVIQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.